Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Increased expression of
manganese superoxide dismutase
(
Mn-SOD
), one of the mitochondrial enzymes involved in the redox system, has been shown to diminish the cytotoxic effects of several anti-cancer modalities, including tumour necrosis factor-alpha, ionizing radiation, certain chemotherapeutic agents and hyperthermia. We asked if
Mn-SOD
is a potential target to augment the sensitivity of cancer cells to various anti-cancer treatments and for this we established stable
Mn-SOD
antisense RNA expressing cell clones from two human colon cancer cell lines, HCT116 (
p53
wild-type) and DLD1 (
p53
mutant-type). Suppression of
Mn-SOD
in HCT116 was accompanied by an increased sensitivity to radiation, hyperthermia and doxorubicin, as compared with findings in controls. The mitochondrial permeability transition, as measured by a decrease of the mitochondrial transmembrane potential was more intensely induced by radiation in HCT116 antisense clones than in the control, an event followed by a greater extent of DNA fragmentation. Apoptosis was also induced by hyperthermia more intensely in HCT116 antisense clones than in the control. On the other hand, DLD1 antisense clones did not exhibit any enhancement of sensitivity to any of these treatments. These data support the possibility that inhibition of
Mn-SOD
activity renders colon cancer cells with wild-type
p53
susceptible to apoptosis induced by radiation, hyperthermia and selected anti-cancer drugs. Therefore, we suggest that
Mn-SOD
could be a target molecule to overcome the resistance to anti-cancer treatments in some colon cancer cells carrying wild-type
p53
.
...
PMID:Suppression of manganese superoxide dismutase augments sensitivity to radiation, hyperthermia and doxorubicin in colon cancer cell lines by inducing apoptosis. 1097 Jun 96
We address the issue of the role of
manganese superoxide dismutase
in tumorigenesis by studying a relatively homogeneous group of tumours for the correlation between amount of this anti-oxidant enzyme and prognosis. The clinical outcome of 30 patients affected by glioblastomas whose
manganese superoxide dismutase
content had been established at the time of first diagnosis is compared. When the survival of patients is stratified according to
manganese superoxide dismutase
level in the tumour, a link of these levels and prognosis can be observed. Patients with high levels of
manganese superoxide dismutase
show a median survival time of 6.11 months, while patients whose tumours display a low amount of MnSOD have a median survival time of 12.17 months. To assess the upstream mechanisms that sustain the increase in
manganese superoxide dismutase
content in brain neuroepithelial tumours, we also studied the expression of
p53
in a series of 17 astrocytomas of various grading. In all tested astrocytomas, high
manganese superoxide dismutase
content is associated with cytoplasmic accumulation of
p53
. Thus glioblastomas can be divided into two distinct groups on the basis of their content of
manganese superoxide dismutase
, having 'better' or 'worse' prognosis, respectively. The use of this protein as a marker may help to define therapeutic strategies in the clinical management of glioblastoma.
...
PMID:The level of manganese superoxide dismutase content is an independent prognostic factor for glioblastoma. Biological mechanisms and clinical implications. 1120 49
Previous studies in our laboratories demonstrated that overexpression of
manganese superoxide dismutase
(
MnSOD
) suppressed both the incidence and multiplicity of papillomas in a DMBA/TPA multi-stage skin carcinogenesis model. The activity of activator protein-1 (AP-1), which is associated with tumor promotion, was reduced in
MnSOD
transgenic mice overexpressing
MnSOD
in the skin, suggesting that
MnSOD
may reduce tumor incidence by suppressing AP-1 activation. In the present study, we report that reduction of
MnSOD
by heterozygous knockout of the
MnSOD
gene (Sod2 -/+,
MnSOD
KO) increased the levels of oxidative damage proteins and the activity of AP-1 following TPA treatment. RNA levels of ornithine decarboxylase (ODC) were also increased, suggesting an increase in cell proliferation in the KO mice. Histological examination confirmed that the number of proliferating cells in DMBA/TPA-treated mouse skin were higher in the KO mice. Interestingly, histological examination also demonstrated greater numbers of apoptotic cells in the KO mice after DMBA/TPA treatment. Evidence of apoptosis, including DNA fragmentation, cytochrome c release from mitochondria, and caspase 3 activation were also observed by biochemical assays of the skin tissues. Apoptosis was associated with an increase in nuclear levels of
p53
as determined by Western analysis. Quantitative immunogold ultrastructural analysis confirmed that
p53
immunoreactive protein levels were increased to a greater level in the nuclei of epidermal cells from
MnSOD
KO mice compared to epidermal nuclei from wild type mice similarly treated. Moreover,
p53
levels further increased in the mitochondria of DMBA/TPA treated mice, and this increase was much greater in the
MnSOD
KO than in the wild type mice, suggesting a link between
MnSOD
deficiency and mitochondrial-mediated apoptosis. Pathological examination reveals no difference in the incidence and frequency of papillomas comparing the KO mice and their wild type littermates. Taken together, these results suggest that: (1)
MnSOD
deficiency enhanced TPA-induced oxidative stress and AP-1 and
p53
levels, consistent with the increase in both proliferation and apoptosis events in the
MnSOD
KO mice, and (2) increased apoptosis may negate increased proliferation in the
MnSOD
deficient mice during an early stage of tumor development.
...
PMID:Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model. 1203 21
The transcription of
manganese superoxide dismutase
(
MnSOD
), expression of which is essential for detoxification of superoxide radicals from mitochondria, has been shown to be regulated in vitro by many factors and conditions including oxidative stress, cytokines, lipopolysaccharide, cytoplasmic myc (c-myc),
p53
and tumour necrosis factors. Here we describe genomic regions in Drosophila melanogaster with regulatory effects on transcription of the
MnSOD
gene at an organism-wide level. To understand the integrated regulation of
MnSOD
expression we screened chromosomes of D. melanogaster to locate deficiencies that altered the expression of
MnSOD
. Suppressors of
MnSOD
were screened by assessing the relative message abundance of
MnSOD
in 149 deletions covering approximately 81% of the Drosophila genome. The chromosomal deficiency Df(2R)017 significantly up-regulated
MnSOD
mRNA by 1.7-fold. Deficiency in four other genomic intervals, Df(1)ct-J4, Df(2L)BSC4, Df(3L)66C-G28 and Df(3R)Scr, down-regulated
MnSOD
expression. Changes in
MnSOD
expression were positively associated with paraquat sensitivity of the deletion genotypes. Thus, at least one candidate enhancer and four candidate suppressors exist in the Drosophila genome to regulate the transcriptional activity of the
MnSOD
gene in vivo.
...
PMID:Genomic regions responsible for manganese superoxide dismutase regulation in Drosophila melanogaster. 1293 16
p53
-mediated apoptosis may involve the induction of redox-controlling genes, resulting in the production of reactive oxygen species. Microarray expression analysis of doxorubicin exposed, related human lymphoblasts,
p53
wild-type (WT) Tk6, and
p53
mutant WTK1 identified the
p53
-dependent up-regulation of
manganese superoxide dismutase
(
MnSOD
) and glutathione peroxidase 1 (GPx). Consensus
p53
binding sequences were identified in human
MnSOD
and GPx promoter regions. A 3-fold increase in the
MnSOD
promoter activity was observed after the induction of
p53
in Li-Fraumeni syndrome (LFS) fibroblast, TR9-7, expressing
p53
under the control of a tetracycline-regulated promoter. An increased protein expression of endogenous
MnSOD
and GPx also positively correlated with the level of
p53
induction in TR9-7 cells. However, catalase (CAT) protein expression remained unaltered after
p53
induction. We also examined the expression of
MnSOD
, GPx, and CAT in a panel of normal or LFS fibroblasts, containing either WT or mutant p53. We found increased
MnSOD
enzymatic activity,
MnSOD
mRNA expression, and
MnSOD
and GPx protein in LFS fibroblasts carrying a WT
p53
allele when compared with homozygous mutant p53 isogenic cells. The CAT protein level was unchanged in these cells. We observed both the release of cytochrome C and Ca(2+) from the mitochondria into the cytoplasm and an increased frequency of apoptotic cells after
p53
induction in the TR9-7 cells that coincided with an increased expression of
MnSOD
and GPx, and the level of reactive oxygen species. The increase in apoptosis was reduced by the antioxidant N-acetylcysteine. These results identify a novel mechanism of
p53
-dependent apoptosis in which
p53
-mediated up-regulation of
MnSOD
and GPx, but not CAT, produces an imbalance in antioxidant enzymes and oxidative stress.
...
PMID:p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. 1505 85
The most important cellular protective mechanisms against oxidative stress are antioxidant enzymes. Their action is based on decomposal of reactive oxygen species (ROS) and their transformation to H2O2. Within the mitochondria
manganese superoxide dismutase
(
MnSOD
) affords the major defense against ROS. In this study we investigated tissue sections from 101 breast carcinomas for the immunohistochemical expression of
MnSOD
protein and these results were assessed in relation to various clinicopathological parameters, in order to clarify the prognostic value of this enzyme. The possible relationship to hormone receptor content, anti-apoptotic protein bcl-2,
p53
and cell proliferation was also estimated. High expression levels were observed, as 79/101 (78,2%) cases expressed strong immunoreactivity. In this study
MnSOD
increased in a direct relationship with tumor grade and is therefore inversely correlated with differentiation (p=0.0004). Furthermore, there was a strong positive correlation between
MnSOD
expression and
p53 protein
immunoreactivity (p=0.0029). The prognostic impact of
MnSOD
expression in determining the risk of recurrence and overall survival with both univariate (long-rang test) and multivariate (Cox regression) methods of analysis was statistically not significant. These results indicate that neoplastic cells in breast carcinomas retain their capability to produce
MnSOD
and thus protected from the possible cellular damage provoked by reactive oxygen species. In addition,
MnSOD
content varies according to the degree of differentiation of breast carcinoma.
...
PMID:Immunohistochemical expression of superoxide dismutase (MnSOD) anti-oxidant enzyme in invasive breast carcinoma. 1516 44
In our previous study, we examined reactive oxygen species (ROS) formation in T lymphocytes following 5 Gy irradiation. We found that ROS formation occurred immediately after irradiation, continued for several hours, and resulted in oxidative DNA damage. Therefore, the origin of the hyper-radiosensitivity of T lymphocytes seemed to be the high production of ROS in the mitochondrial DNA following irradiation. In the succeeding study, we examined radiation-induced ROS formation, oxidative DNA damage, early apoptotic changes, and mitochondrial membrane dysfunction in the human osteosarcoma cell line HS-Os-1. We found that ROS formation and oxidative DNA damage were actually scarcely seen after irradiation of up to 30 Gy in these cells, that mitochondrial membrane potential was preserved, and that apoptotic changes were not demonstrated despite the relatively high-dose irradiation of 30 Gy. In the present study, we examined the immunocytochemical characteristics of the apoptotic-resistance of the HS-Os-1 cell line against irradiation in order to clarify its possible implications regarding radiosensitivity. The results showed that these cells lack
P53
and Bax protein expression, and strong peroxidase activity was confirmed in the nuclei of the cells. Moreover, SODII (
manganese superoxide dismutase
II) protein expression was gradually increased in spite of irradiation of up to 30 Gy. Therefore, it is concluded that HS-Os-1 cells are originally apoptotic-resistant and that the cells possess a strong ability to scavenge for free radicals. To convert these cells to a state of apoptotic-susceptibility, a powerful oxidant such as hydrogen peroxide might exert such an effect in terms of the production of hydroxyl radicals in lysosomes in the cells as shown in our previous studies. The origin of the radioresistance of the human osteosarcoma cell line HS-Os-1 is considered to to be low degree of ROS formation following irradiation, reflecting the strong scavenging ability of these cells for free radicals including hydroxyl radicals.
...
PMID:Immunocytochemical characteristics of human osteosarcoma cell line HS-Os-1: possible implication in apoptotic resistance against irradiation. 1528 91
Growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) is a new member of the transforming growth factor beta (TGF-beta) superfamily, which has most recently been found in activated macrophages (MPhi). We have now investigated GDF-15/MIC-1 in human MPhi after exposure to oxidized low-density lipoproteins (oxLDL) related mediators in vitro and in arteriosclerotic carotid arteries. Using RT-PCR and Western blotting a pronounced induction of GDF-15/MIC-1 expression by oxLDL, C6-ceramide, tumor necrosis factor (TNFalpha) and hydrogen peroxide (H2O2) was found in cultured human MPhi. In 11 human arteriosclerotic carotid arteries, immunohistochemical analyses supported by computer-assisted morphometry and regression analyses demonstrated a significant colocalization of GDF-15/MIC-1 immunoreactivity (IR) with oxLDL IR and
manganese superoxide dismutase
(
MnSOD
) IR in CD68 immunoreactive (ir) MPhi, which were also expressing AIF-IR (apoptosis-inducing factor), caspase-3-IR (CPP32), PARP-IR, c-Jun/AP-1-IR and
p53
-IR. Our data suggest that GDF-15/MIC-1 is inducible in human MPhi by oxLDL and its mediators in vitro and is supposed to contribute to oxidative stress dependent consequences in arteriosclerotic plaques, e.g. modulating apoptosis and inflammatory processes in activated MPhi.
...
PMID:Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions. 1545 68
Evidence implies that satellite cells could play some limiting role in aged muscle undergoing repair or maintenance of mass, which is of potential clinical concern as this could contribute to sarcopenia. Further, insufficient information is available concerning the cellular mechanisms responsible for the lower rat satellite cell proliferation in old animals. Thus, it was hypothesized that the following proteins would be increased in nuclei of satellite cells from old rat skeletal muscle: the cyclin-dependent kinase (CDK) inhibitors p21(WAF1/CIP1) and p27(Kip1) as well as the transcription factors
p53
and Forkhead box, subgroup O1 (FOXO1). In addition, the NAD(+)-dependent histone deacetylase SIRT1, the mammalian ortholog of the yeast SIR2 (silence information regulator 2) and a member of the Sirtuin family, was hypothesized to decrease in satellite cell nuclei of old rats. Old satellite cells (30-months old) exhibited a lesser number of BrdU-positive cells as compared to satellite cells (3-months old) from young growing animals. Western blot analysis demonstrated that nuclei of old satellite cells accumulated the cell cycle inhibitors p21(WAF1/CIP1) and p27(Kip1). In addition, nuclear
p53
and FOXO1 proteins were also higher in old satellite cells than in cells from young growing animals. These data indicated both
p53
/p21(WAF1/CIP1)- and FOXO1/p27(Kip1)-dependent pathways might contribute to the age-associated decrease in satellite cell proliferation. Cytoplasmic
manganese superoxide dismutase
(
MnSOD
), a gene driven by FOXO1, was higher in old satellite cells. Unexpectedly, nuclear SIRT1 was also increased in old satellite cells compared with satellite cells from young growing animals. The physiological significance of enhanced nuclear SIRT1 expression in old satellite cells remains elusive at this time. In summary, satellite cells in old rats have nuclear accumulation of proteins inhibiting the cell cycle as compared to young, growing animals.
...
PMID:Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. 1550 Oct 22
Studies in our laboratories showed that overexpression of
manganese superoxide dismutase
(
MnSOD
) reduced tumor incidence in a multistage skin carcinogenesis mouse model. However, reduction of
MnSOD
by heterozygous knockout of the
MnSOD
gene (
MnSOD
KO) did not lead to an increase in tumor incidence, because a reduction of
MnSOD
enhanced both cell proliferation and apoptosis. The present study extends our previous studies in the
MnSOD
KO mice and shows that apoptosis in mouse epidermis occurred prior to cell proliferation (6 versus 24 hours) when treated with tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). To investigate the possibility that a timed administration of SOD following apoptosis but before proliferation may lead to suppression of tumor incidence, we applied a SOD mimetic (MnTE-2-PyP(5+)) 12 hours after each TPA treatment. Biochemical studies showed that MnTE-2-PyP(5+) suppressed the level of protein carbonyls and reduced the activity of activator protein-1 and the level of proliferating cellular nuclear antigen, without reducing the activity of
p53
or DNA fragmentation following TPA treatment. Histologic examination confirmed that MnTE-2-PyP(5+) suppressed mitosis without interfering with apoptosis. Remarkably, the incidence and multiplicity of skin tumors were reduced in mice that received MnTE-2-PyP(5+) before cell proliferation. These results show a novel strategy for an antioxidant approach to cancer intervention.
...
PMID:A mechanism-based antioxidant approach for the reduction of skin carcinogenesis. 1573 27
<< Previous
1
2
3
4
5
6
7
Next >>